CVS Health schedules November 4 results. CVS Health stock gains 1.30 percent

Published on 10/20/2026 at 11:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 revenue reached USD 106.10 billion, up 7.30 percent. CVS Health stock costs EUR 82.70 on October 20, 2026, 1.30 percent above Xetra close.

November results and earnings context

CVS Health will discuss third-quarter results on November 4, 2026, at 8:00 a.m. ET.
Second-quarter 2026 revenue reached USD 106.10 billion, up 7.30 percent year over year.
CVS Health stock trades at EUR 82.70 at 10:49 a.m. CEST at Lang & Schwarz on October 20, 2026, 1.30 percent above the Xetra close of October 19, 2026.

Isometrische 3D-Illustration der Gesundheitsversorgungskette von Produktion über Apotheke bis Patient — CVS Health Corp. isometrisches 3D-Diagramm der Wertschöpfungskette von Pharma bis Patient, ISIN US1266501006, Illustration mit AI erstellt.

CVS Health (ISIN US1266501006) has set November 4, 2026, for its third-quarter results. CVS Health stock was trading at EUR 82.70 at Lang & Schwarz at 10:49 a.m. CEST on October 20, 2026, 1.30 percent above the Xetra close of October 19, 2026.

Results date brings the next test

CVS Health said on October 5, 2026, that it will discuss third-quarter 2026 financial results with analysts on November 4 at 8:00 a.m. ET. The company identifies health insurance, health services, pharmacy and prescription drug coverage as its four operating strengths.

The second-quarter comparison gives investors a measurable starting point. CVS Health generated USD 106.10 billion in revenue for the quarter ended June 30, 2026, compared with USD 100.03 billion expected by analysts, while adjusted earnings per share reached USD 2.58 versus a USD 1.87 consensus estimate, according to MarketBeat. Revenue was 7.30 percent higher than in the year-earlier quarter.

Three dated steps in the earnings story

On May 6, 2026, CVS Health reported first-quarter revenue of USD 100.40 billion. On August 5, 2026, second-quarter revenue reached USD 106.10 billion and adjusted earnings per share came to USD 2.58. On October 5, 2026, the company scheduled its November 4 third-quarter discussion, according to TickerScout and the company release.

Which dates matter next?

CVS Health shareholders are due to be recorded for the USD 0.665 dividend on October 22, 2026, with payment scheduled for November 2, 2026, according to Simply Wall St. The November 4 report follows those shareholder dates and will provide the next operating checkpoint.

What does Q2 mean for CVS Health stock?

The numbers show a company growing revenue while the market waits to see whether the pace can continue into the second half. Management's fiscal 2026 outlook includes adjusted earnings per share of USD 7.90 to USD 8.10 and operating cash flow of at least USD 11.50 billion, according to Trefis. That guidance makes the November revenue and earnings figures the key test for the current valuation.

Valuation ahead of the November report

CVS Health had a market capitalization of USD 118.50 billion as of October 19, 2026. Its primary listing is the NYSE under ticker CVS, and its 52-week range was USD 69.51 to USD 110.68. The stock's euro quotation stood at EUR 82.70 at Lang & Schwarz on October 20, 2026, at 10:49 a.m. CEST, 1.30 percent above the Xetra close of October 19, 2026.

The further course of trading is shown by the continuously updated real-time quote of CVS Health stock.